Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in September:
- Citi 2025 Biopharma Back to School Summit on Wednesday, September 3 at 9:00 a.m. Eastern Time
- 2025 Wells Fargo Healthcare Conference on Thursday, September 4 at 9:30 a.m. Eastern Time
A live webcast of Kiniksa’s presentations will be accessible through the Investors & Media section of the company’s website at . A replay of the events will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit .
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
